Entry Detail



General Information

Database ID:exR0000109
RNA Name:ACACA
RNA Type:mRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):37084992End Site(bp):37406836
External Links:ENSG00000278540



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
XPNPEP3
chr22
40857077
40932815
+
SORT1
chr1
109309568
109397918
-
LSM2
chr6
31797396
31806966
-
RB1CC1
chr8
52622458
52745843
-
ATXN1L
chr16
71845976
71885268
+
EIF3F
chr11
7970251
8001862
+
RPL10A
chr6
35468401
35470785
+
RAB40B
chr17
82654973
82698698
-
GANAB
chr11
62624826
62646726
-
NPC2
chr14
74476192
74494177
-
PMAIP1
chr18
59899948
59904306
+
TCF19
chr6
31158547
31167159
+
ATP2A2
chr12
110280756
110351093
+
METTL9
chr16
21597218
21657473
+
KMT2D
chr12
49018975
49059774
-
GAPDH
chr12
6534512
6538374
+
TLE3
chr15
70047790
70098176
-
SEPHS1
chr10
13317428
13348298
-
AC079447.1
chr2
99141485
99322741
+
FBXW11
chr5
171861549
172006873
-
FBRS
chr16
30658431
30670810
+
FAM126A
chr7
22889371
23014130
-
IQGAP1
chr15
90388242
90502239
+
CACHD1
chr1
64470129
64693058
+
PDE8A
chr15
84980440
85139145
+
DVL1
chr1
1335276
1349418
-
SIMC1
chr5
176238367
176345991
+
MRPL57
chr13
21176658
21179084
+
MTRNR2L8
chr11
10507894
10509186
-
DDX6
chr11
118747763
118791164
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-541-3p
chr14
101064548
101064569
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC008514.1
chr5
170747047
170788650
-
AD000090.1
chr19
35557956
35581954
+
AC079601.2
chr12
42459366
42466128
+
AC138761.1
chr17
22266395
22288301
+
AP001496.2
chr18
5232876
5238526
-
MIR663AHG
chr20
26167817
26251546
-
MMP25-AS1
chr16
3037400
3059370
-
RMRP
chr9
35657751
35658018
-
RMST
chr12
97430884
97598415
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.